Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
99.00
-2.60 (-2.56%)
Last updated: Jan 19, 2026, 9:36 AM HKT

HKG:2659 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
Net Income
-380.24-364.43-160.4
Depreciation & Amortization
32.3231.3622.21
Other Amortization
1.090.770.22
Loss (Gain) From Sale of Assets
0.080.080.03
Loss (Gain) on Equity Investments
0.480.610.92
Stock-Based Compensation
129.86153.15-
Other Operating Activities
4.783.340.69
Change in Accounts Receivable
2.311.86-2
Change in Inventory
-0.713.36-0.63
Change in Accounts Payable
72.7344.111.61
Change in Unearned Revenue
3.43.20.4
Change in Other Net Operating Assets
-18.2-97.18-13.26
Operating Cash Flow
-152.1-219.78-140.21
Capital Expenditures
-96.71-118.27-136.37
Sale of Property, Plant & Equipment
0.440.15-
Other Investing Activities
3.7-4-
Investing Cash Flow
-92.58-122.12-136.37
Long-Term Debt Issued
-161.6648.47
Long-Term Debt Repaid
--71.6-41.49
Net Debt Issued (Repaid)
82.5890.066.98
Issuance of Common Stock
490.1460.1120.25
Other Financing Activities
-10.59-6.97-4.3
Financing Cash Flow
562.1543.2122.93
Foreign Exchange Rate Adjustments
0.441.192.97
Net Cash Flow
317.86202.49-150.68
Free Cash Flow
-248.81-338.06-276.58
Free Cash Flow Margin
-533.26%-5487.91%-3991.02%
Free Cash Flow Per Share
-4.42-6.32-5.47
Cash Interest Paid
6.535.514.3
Levered Free Cash Flow
--214.42-
Unlevered Free Cash Flow
--211.58-
Change in Working Capital
59.54-44.66-3.88
Source: S&P Global Market Intelligence. Standard template. Financial Sources.